The ability to accurately test for Covid-19 infection is critical to diagnosing and treating ill patients and tracking infection rates and trends in various geographic locations. Solgent’s DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcription-polymerase chain reaction diagnostic kit that amplifies and tests a specific gene sequence of the COVID-19 virus. The U.S. Federal Emergency Management Agency (FEMA) has chosen Solvent’s highly trusted DiaPlexQ for stockpile procurement.
This kit is a Multiplex OneStep qRT-PCR based assay system providing qualitative detection of 2019-nCoV. Control template (2019-nCoV) is included. The DiaPlexQ provides detection for the target regions of ORF1a and N gene using nasopharyngeal swab, oropharyngeal swab, or sputum specimen samples.
The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is CE certified and, as with all of Blueflame Medical’s products, vetted twice for quality assurance and best practice.